NCT07058571 Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention
| NCT ID | NCT07058571 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Pittsburgh Healthcare System |
| Condition | Blood Cancers |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2015-04-03 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2015-04-03 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background. This study aims to evaluate the effectiveness of a telehealth-mediated lifestyle intervention program tailored for veterans with blood cancer, focusing on improving health-related quality of life, mental health, and pain outcomes. The hypothesis posits that the telehealth-delivered program will lead to significant improvements in these areas, specifically targeting veterans undergoing treatment or in post-treatment phases. Objective. Recognizing the unique experiences of veterans, especially those in rural or underserved regions, this study seeks to provide insights into the feasibility and impact of telehealth-based lifestyle interventions for this distinct population. Methods. The pilot trial will enroll 30 veterans from the H. John Heinz III VA. Participants will complete baseline web-based surveys assessing demographics, occupational performance, and telehealth preparedness. The intervention comprises progressive resistance and aerobic exercises delivered via telehealth by a health coach, starting with a live supervised session followed by regular remote sessions. Each participant will engage in exercise sessions coordinated through the Veteran's Video Connect (VVC) application, with ongoing communication facilitated via email. This setup allows the health coach to adjust exercise intensity based on real-time symptom feedback. To address potential technology literacy biases, the VVCMatch assessment will categorize veterans as "technology prepared" or in need of additional education. Those requiring support will receive guidance on using the VVC app before starting the intervention. Additionally, participants will receive dietary consultations from the Leukemia and Lymphoma Society, independent of the research team. Outcome measures include assessments of symptoms, fatigue, function, mental health, and pain, along with evaluations of the intervention's usability through surveys on perceived usefulness and ease of use. These assessments aim to detect meaningful changes and ensure the intervention's effectiveness and acceptability among veterans.
Eligibility Criteria
Inclusion Criteria: * Living with blood cancer * Physically willing and able to perform 30-90 minutes of exercise a minimum of 2 times per week Exclusion Criteria: * Veterans who are unable to perform 30-90 minutes of exercise twice a week * Veterans with significant disabilities related to balance or motion that would cause a safety risk * Veterans without a smart personal device (smart phone, tablet, or computer) and internet connection (for example, cellular or WIFI connection) * Veterans who are pregnant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07058571 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07058571 currently recruiting?
Yes, NCT07058571 is actively recruiting participants. Contact the research team at Julie.Faieta@va.gov for enrollment information.
Where is the NCT07058571 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07058571 clinical trial?
NCT07058571 is sponsored by VA Pittsburgh Healthcare System. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.